Literature DB >> 22498258

Melanoma-derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signature.

Tao Wang1, Yingbin Ge, Min Xiao, Alfonso Lopez-Coral, Rikka Azuma, Rajasekharan Somasundaram, Gao Zhang, Zhi Wei, Xiaowei Xu, Frank J Rauscher, Meenhard Herlyn, Russel E Kaufman.   

Abstract

The presence of tumor-associated macrophages (TAMs) in melanomas is correlated with a poor clinical prognosis. However, there is limited information on the characteristics and biological activities of human TAMs in melanomas. In this study, we developed an in vitro method to differentiate human monocytes to macrophages using modified melanoma-conditioned medium (MCM). We demonstrate that factors from MCM-induced macrophages (MCMI-Mφ) express both M1-Mφ and M2-Mφ markers and inhibit melanoma-specific T-cell proliferation. Furthermore, microarray analyses reveal that the majority of genes up-regulated in MCMI-Mφ are associated with tumor invasion. The most strikingly up-regulated genes are CCL2 and MMP-9. Consistent with this, blockade of both CCL-2 and MMPs diminish MCMI-Mφ-induced melanoma invasion. Finally, we demonstrated that both MCMI-Mφ and in vivo TAMs express the pro-invasive, melanoma-associated gene, glycoprotein non-metastatic melanoma protein B. Our study provides a framework for understanding the mechanisms of cross-talk between TAMs and melanoma cells within the tumor microenvironment.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22498258      PMCID: PMC3615702          DOI: 10.1111/j.1755-148X.2012.01005.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  52 in total

1.  Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha.

Authors:  Stephen C Robinson; Kate A Scott; Frances R Balkwill
Journal:  Eur J Immunol       Date:  2002-02       Impact factor: 5.532

2.  Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha.

Authors:  H Torisu; M Ono; H Kiryu; M Furue; Y Ohmoto; J Nakayama; Y Nishioka; S Sone; M Kuwano
Journal:  Int J Cancer       Date:  2000-01-15       Impact factor: 7.396

3.  Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A.

Authors:  Michelle L Varney; Sonny L Johansson; Rakesh K Singh
Journal:  Melanoma Res       Date:  2005-10       Impact factor: 3.599

4.  Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients.

Authors:  M G Bernengo; P Quaglino; N Cappello; F Lisa; S Osella-Abate; M T Fierro
Journal:  Melanoma Res       Date:  2000-02       Impact factor: 3.599

Review 5.  Autocrine and paracrine regulation by cytokines and growth factors in melanoma.

Authors:  E Lázár-Molnár; H Hegyesi; S Tóth; A Falus
Journal:  Cytokine       Date:  2000-06       Impact factor: 3.861

6.  Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.

Authors:  T Mäkitie; P Summanen; A Tarkkanen; T Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-06       Impact factor: 4.799

7.  CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.

Authors:  Kam Fai Tse; Michael Jeffers; Vincent A Pollack; Denise A McCabe; Melanie L Shadish; Nikolai V Khramtsov; Craig S Hackett; Suresh G Shenoy; Bing Kuang; Ferenc L Boldog; John R MacDougall; Luca Rastelli; John Herrmann; Michael Gallo; Gadi Gazit-Bornstein; Peter D Senter; Damon L Meyer; Henri S Lichenstein; William J LaRochelle
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

8.  Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft.

Authors:  Silvina Gazzaniga; Alicia I Bravo; Angelo Guglielmotti; Nico van Rooijen; Fabricio Maschi; Annunciata Vecchi; Alberto Mantovani; José Mordoh; Rosa Wainstok
Journal:  J Invest Dermatol       Date:  2007-04-26       Impact factor: 8.551

Review 9.  Tumor promotion by tumor-associated macrophages.

Authors:  Chiara Porta; Biswas Subhra Kumar; Paola Larghi; Luca Rubino; Alessandra Mancino; Antonio Sica
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

10.  Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells.

Authors:  Dorothée Duluc; Yves Delneste; Fang Tan; Marie-Pierre Moles; Linda Grimaud; Julien Lenoir; Laurence Preisser; Ignacio Anegon; Laurent Catala; Norbert Ifrah; Philippe Descamps; Erick Gamelin; Hugues Gascan; Mohamed Hebbar; Pascale Jeannin
Journal:  Blood       Date:  2007-09-11       Impact factor: 22.113

View more
  28 in total

Review 1.  Forkhead Box O1 Regulates Macrophage Polarization Following Staphylococcus aureus Infection: Experimental Murine Data and Review of the Literature.

Authors:  Yu-Chen Wang; Hong-Di Ma; Xue-Ying Yin; Yin-Hu Wang; Qing-Zhi Liu; Jing-Bo Yang; Qing-Hua Shi; Baolin Sun; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 2.  The role of tumor microenvironment in melanoma therapy resistance.

Authors:  Rajasekharan Somasundaram; Meenhard Herlyn; Stephan N Wagner
Journal:  Melanoma Manag       Date:  2016-02-12

3.  In Vitro Differentiation of Tumor-Associated Macrophages from Monocyte Precursors with Modified Melanoma-Conditioned Medium.

Authors:  Tao Wang; Russel E Kaufman
Journal:  Methods Mol Biol       Date:  2021

4.  Identification of Caspase-6 as a New Regulator of Alternatively Activated Macrophages.

Authors:  Yongfang Yao; Qian Shi; Bing Chen; Qingsong Wang; Xinda Li; Long Li; Yahong Huang; Jianguo Ji; Pingping Shen
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

5.  Distinct role of FoxO1 in M-CSF- and GM-CSF-differentiated macrophages contributes LPS-mediated IL-10: implication in hyperglycemia.

Authors:  Sangwoon Chung; Ravi Ranjan; Yong Gyu Lee; Gye Young Park; Manjula Karpurapu; Jing Deng; Lei Xiao; Ji Young Kim; Terry G Unterman; John W Christman
Journal:  J Leukoc Biol       Date:  2014-11-24       Impact factor: 4.962

6.  BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth.

Authors:  Tao Wang; Min Xiao; Yingbin Ge; Clemens Krepler; Eric Belser; Alfonso Lopez-Coral; Xiaowei Xu; Gao Zhang; Rikka Azuma; Qin Liu; Rui Liu; Ling Li; Ravi K Amaravadi; Wei Xu; Giorgos Karakousis; Tara C Gangadhar; Lynn M Schuchter; Melissa Lieu; Sanika Khare; Molly B Halloran; Meenhard Herlyn; Russel E Kaufman
Journal:  Clin Cancer Res       Date:  2015-01-23       Impact factor: 12.531

Review 7.  Mechanisms and prevention of UV-induced melanoma.

Authors:  Ashley Sample; Yu-Ying He
Journal:  Photodermatol Photoimmunol Photomed       Date:  2017-08-02       Impact factor: 3.254

8.  1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas.

Authors:  Yanyu Zhang; Yuan Xie; Liqun He; Jiefu Tang; Qiyuan He; Qingze Cao; Langjun Cui; Wei Guo; Kai Hua; Anna Dimberg; Liang Wang; Lei Zhang
Journal:  Cell Oncol (Dordr)       Date:  2020-09-11       Impact factor: 6.730

9.  The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma.

Authors:  Orsi Giricz; Yongkai Mo; Kimberly B Dahlman; Xiomaris M Cotto-Rios; Chiara Vardabasso; Hoa Nguyen; Bernice Matusow; Matthias Bartenstein; Veronika Polishchuk; Douglas B Johnson; Tushar D Bhagat; Rafe Shellooe; Elizabeth Burton; James Tsai; Chao Zhang; Gaston Habets; John M Greally; Yiting Yu; Paraic A Kenny; Gregg B Fields; Kith Pradhan; E Richard Stanley; Emily Bernstein; Gideon Bollag; Evripidis Gavathiotis; Brian L West; Jeffrey A Sosman; Amit K Verma
Journal:  JCI Insight       Date:  2018-07-26

Review 10.  Effects of BRAF mutations and BRAF inhibition on immune responses to melanoma.

Authors:  Kristina M Ilieva; Isabel Correa; Debra H Josephs; Panagiotis Karagiannis; Isioma U Egbuniwe; Michiala J Cafferkey; James F Spicer; Mark Harries; Frank O Nestle; Katie E Lacy; Sophia N Karagiannis
Journal:  Mol Cancer Ther       Date:  2014-11-10       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.